You are here

RSV

FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks

FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks

CNBC

Flag link:

Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions

Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions

Fierce Biotech

Flag link:

Icosavax receives fast track designation for IVX-A12 vaccine candidate

Icosavax receives fast track designation for IVX-A12 vaccine candidate

Pharmaceutical Business Review

Flag link:

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Fierce Pharma

Flag link:

Spybiotech seeks new vaccines

Spybiotech seeks new vaccines

EP Vantage

Oxford University

Flag link:

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

Forbes

Moderna Therapeutics

Flag link:

GSK vaccine R&D head touts consistency of RSV data but is mum on restarting maternal trial

GSK vaccine R&D head touts consistency of RSV data but is mum on restarting maternal trial

Fierce Biotech

Flag link:

FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

BioPharma Dive

Flag link:

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

BioSpace

Moderna Therapeutics

breakthrough therapy

Flag link:

Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education

Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education

Endpoints

pharma marketing

Flag link:

Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Motley Fool

Moderna Therapeutics

Flag link:

Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data

Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data

Fierce Biotech

Moderna Therapeutics

Flag link:

FDA starts review of Sanofi, AZ antibody for RSV prevention

FDA starts review of Sanofi, AZ antibody for RSV prevention

Pharmaphorum

Flag link:

Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax

Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax

Fierce Biotech

Moderna Therapeutics

Flag link:

Pfizer's RSV vaccine rush gets FDA boost with priority review

Pfizer's RSV vaccine rush gets FDA boost with priority review

Fierce Biotech

priority review

Flag link:

Pediatric health groups call for national emergency to fight respiratory illnesses

Pediatric health groups call for national emergency to fight respiratory illnesses

The Hill

Flag link:

Blue Lake reports positive data from Phase I RSV vaccine trial

Blue Lake reports positive data from Phase I RSV vaccine trial

Clinical Trials Arena

Blue Lake Biotechnology

clinical trials

Flag link:

Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators

Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators

Endpoints

Flag link:

With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer

With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer

Fierce Biotech

Flag link:

Pages